Rekvina Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 526075 | NSE: | Trading | Small Cap

Rekvina Labs Share Price

4.50 0.00 0.00%
as on 13-Dec'21 18:01

DeciZen - make an informed investing decision on Rekvina Labs

M-Cap below 100cr DeciZen not available

Rekvina Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
2.7 Cr.
52-wk low:
4.5
52-wk high:
4.5

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

The key valuation ratios of Rekvina Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is a good buy now?

No data found

10 Year X-Ray of Rekvina Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % 3.2%4.2%0.8%-10.4%-3.3%-12.6%-30.5%1.7%-51.3%-125.9%-
Value Creation
Index
-0.8-0.7-0.9-1.7-1.2-1.9NANANANA-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.10.100.10000000
Sales YoY Gr.-0%-62.5%100%-100%NANANANANA-
Adj EPS 000-0.1-0-0.1-0.40-0.1-0.10
YoY Gr.-33.3%-75%-1000%NANANANANANA-
BVPS (₹) 1.11.10.90.80.80.70.30.30.200.1
Adj Net
Profit
000-0.10-0.1-0.30-0.1-0.10
Cash Flow from Ops. 0000000.1000-
Debt/CF from Ops. 00-0.5-0.216.9-8.90000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -100%NANANA
Adj EPS -217.7%NANANA
BVPS-35.9%-52.3%-57.5%-86.7%
Share Price -12.2% -2.3% - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on
Equity %
2.63.30.6-10.6-3.9-17.9-89.61.5-51.4-147.80
Op. Profit
Mgn %
26.235.915.4-89.9000000NAN
Net Profit
Mgn %
21.228.812.2-90.1000000NAN
Debt to
Equity
00000.40.50000-
Working Cap
Days
1,6972,0045,0592,5490000000
Cash Conv.
Cycle
-67,2190-1,342-4,9400000000

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Rekvina Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 0.1 -
Reserves (₹ Cr.) -3 -
P/BV 31.29 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 4.50 / 4.50
All Time Low / High (₹) 0.50 / 77.75
Market Cap (₹ Cr.) 2.7
Equity (₹ Cr.) 3
Face Value (₹) 5
Industry PE 58.5

Management X-Ray of Rekvina Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Rekvina Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales0.030.0600000000
Operating Expenses 0.030.120.050.100.130.150.060.0700.02
Manufacturing Costs000000.010000
Material Costs0000000000
Employee Cost 0.010.010000.080000
Other Costs 0.020.110.050.100.130.060.060.0700.02
Operating Profit 0.01-0.06-0.05-0.10-0.13-0.15-0.06-0.070-0.02
Operating Profit Margin (%) 15.4%-89.9%--------
Other Income 000.030.020.010.150000
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0000000000
Profit Before Tax 0-0.06-0.02-0.08-0.120-0.06-0.070-0.02
Tax 00000.13000.0100
Profit After Tax 0-0.06-0.02-0.08-0.250-0.06-0.080-0.02
PAT Margin (%) 12.2%-90.0%--------
Adjusted EPS (₹)0.0-0.10.0-0.1-0.40.0-0.1-0.10.00.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 0.560.500.490.410.150.160.090.010.010
Share Capital 3.013.013.013.013.013.013.013.013.013.01
Reserves -2.45-2.51-2.53-2.61-2.86-2.86-2.92-3-3-3.02
Minority Interest0000000000
Debt0.010.010.170.21000000
Long Term Debt0000000000
Short Term Debt0.010.010.170.21000000
Trade Payables0.090.130.130.190.140.120.150.180.110.11
Others Liabilities 000000000.080.09
Total Liabilities 0.660.640.790.800.290.280.240.190.200.20

Fixed Assets

Gross Block0.510.510.510.510.510.510.510.510.510.51
Accumulated Depreciation0.370.370.370.370.370.370.370.370.370.37
Net Fixed Assets0.150.150.150.150.150.150.150.150.150.15
CWIP 0000000000
Investments 0.050.050.050.050.050.050.050.050.050.05
Inventories0000000000
Trade Receivables0.250.280.250.260.0100000
Cash Equivalents 00.030.130.150.020.01000.010.01
Others Assets0.210.140.210.200.060.070.05000
Total Assets 0.660.640.790.800.290.280.240.190.200.20

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -0.02-0.040.01-0.020.08-0.01-0.01-0.040.010
PBT 0-0.06-0.02-0.08-0.120-0.06-0.080-0.02
Adjustment 0000000000
Changes in Working Capital -0.030.010.030.060.33-0.020.060.040.010.02
Tax Paid 0000-0.1300000
Cash Flow From Investing Activity 0.020.07-0.0700000.0400
Capex 0000000000
Net Investments 00-0.070000000
Others 0.020.07000000.0400
Cash Flow From Financing Activity 0.0100.160.04-0.2100000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0.0100.160.04-0.2100000
Net Cash Flow 00.030.100.01-0.12-0.01-0.0100.010
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)0.64-10.61-3.89-17.91-89.611.54-51.4-147.84-0.33N/A
ROCE (%)0.81-10.39-3.28-12.59-30.451.73-51.32-125.91-0.1N/A
Asset Turnover Ratio0.050.100000000
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days2,6351,53400000000
Inventory Days0000000000
Payable Days0000000000

Rekvina Laboratories Ltd Stock News

Rekvina Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Rekvina Labs on 13-Dec-2021 18:01 is ₹4.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-Dec-2021 18:01 the market cap of Rekvina Labs stood at ₹2.71.
The latest P/E ratio of Rekvina Labs as of 13-Dec-2021 18:01 is 0.00.
The latest P/B ratio of Rekvina Labs as of 13-Dec-2021 18:01 is 31.29.
The 52-week high of Rekvina Labs is ₹4.50 and the 52-week low is ₹4.50.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rekvina Labs is ₹0.00 ( Cr.) .

About Rekvina Laboratories Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.